杰龙 GERN 深 沪
等待开盘 08-25 09:30:00 美东时间
1.52
0.000
0.00%
华盛通- 最 高1.55
- 今 开1.53
- 成交量 1310.94万股
- 最 低 1.44
- 昨 收 1.52
- 总市值 9.77亿
- 52周最高 2.01
- 市盈率 静 --
- 换手率 2.04%
- 52周最低 1.04
- 委 比 -20.19%
- 总股本 6.42亿
- 历史最高 7.79
- 量 比 2.11
- 振 幅 7.24%
- 历史最低 0.75
- 每 手 1
- 风险率 0.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation granted stock options to six new employees on August 17, 2026, totaling 311,250 shares with an exercise price of $1.53 per share, equal to the closing price on the grant date. The options vest over four years, with 12.5% vesting after six months of employment and the remainder vesting quarterly over the next 42 months, contingent on continued employment. The awards were made under the Nasdaq Listing Rule 5635(c)(4) and Geron’s 2...
08-18 20:01
Geron’s RYTELO Drives Revenue as Trial Risks Linger
Geron Corporation (($GERN)) has held its Q2 earnings call. Read on for the main...
08-17 08:27
Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Geron Corporation reported Q2 2026 financial results, achieving $57.5 million in net product revenue for RYTELO® (imetelstat), a 11% increase from Q1 2026. The company reaffirmed its 2026 guidance, expecting net product revenue between $220 million and $240 million, with total operating expenses in the range of $230 million to $240 million. Geron ended Q2 2026 with $327 million in cash, cash equivalents, restricted cash, and marketable securities...
08-05 11:00
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation granted stock options to five new employees, totaling 202,500 shares, as an inducement for employment. The options have an exercise price of $1.44 per share, a 10-year term, and vest over four years, with 12.5% vesting after six months and the remainder vesting quarterly. The awards were made under Nasdaq Listing Rule 5635(c)(4) and Geron's 2018 Inducement Award Plan. Geron is a biopharmaceutical company focused on blood cancer ...
07-22 20:01
Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026
Geron Corporation, a biopharmaceutical company focused on blood cancer treatments, will release its Q2 2026 financial results and business highlights on August 5, 2026, via press release. A conference call and webcast will follow at 8:00 a.m. ET. Geron's lead product, RYTELO® (imetelstat), is approved for certain myelodysplastic syndromes and is being tested in myelofibrosis. More info available on www.geron.com.
07-22 11:00
香港政府再度委任黄杰龙教授为能源咨询委员会主席并公布新一届成员名单 任期两年
7月10日，香港政府公布，再度委任黄杰龙教授为能源咨询委员会主席，并委任18位社会人士为委员会成员，任期两年，由2026年7月15日起生效。
07-10 13:44
主题圆桌：生命的新算法，AI重构医疗产业全链路｜36氪WAVES2026新浪潮
“2026年，创投圈的浪潮再次翻涌：AI从技术概念走进产业深水区，硬科技创业从“小众赛道” 变成“主流共识”，年轻的创业者们正在用代码和双手，重新定义中国创新的...
06-24 15:31
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation granted stock options to purchase 690,000 shares to eight new employees. The options, priced at $1.23 per share, vest over four years with 12.5% after six months and the rest in equal monthly installments. The awards were approved by the Compensation Committee under Nasdaq Listing Rule 5635(c)(4) and the 2018 Inducement Award Plan. Geron is a biopharmaceutical company focused on treating blood cancers, with its lead product, RYT...
06-18 20:01
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
<p>Geron Corporation granted stock options to five new employees on May 15, 2026, totaling 333,750 shares. The options have an exercise price of $1.29 per share, a ten-year term, and vest over four years. The first 12.5% vests after six months of employment, with the remaining shares vesting in equal installments over the next 42 months. The awards were approved by the Compensation Committee under Nasdaq Listing Rule 5635(c)(4) and the 2018 Induc...
05-18 20:01
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
